Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis
- PMID: 27848951
- PMCID: PMC5433921
- DOI: 10.1038/mi.2016.98
Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis
Abstract
Although genetic polymorphisms in NOD2 (nucleotide-binding oligomerization domain-containing 2) have been associated with the pathogenesis of Crohn's disease (CD), little is known regarding the role of wild-type (WT) NOD2 in the gut. To date, most murine studies addressing the role of WT Nod2 have been conducted using healthy (ileitis/colitis-free) mouse strains. Here, we evaluated the effects of Nod2 deletion in a murine model of spontaneous ileitis, i.e., the SAMP1Yit/Fc (SAMP) strain, which closely resembles CD. Remarkably, Nod2 deletion improved both chronic cobblestone ileitis (by 50% assessed, as the % of abnormal mucosa at 24 wks of age), as well as acute dextran sodium sulfate (DSS) colitis. Mechanistically, Th2 cytokine production and Th2-transcription factor activation (i.e., STAT6 phosphorylation) were reduced. Microbiologically, the effects of Nod2 deletion appeared independent of fecal microbiota composition and function, assessed by 16S rRNA and metatranscriptomics. Our findings indicate that pharmacological blockade of NOD2 signaling in humans could improve health in Th2-driven chronic intestinal inflammation.
Figures
Similar articles
-
NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.Cell Mol Gastroenterol Hepatol. 2020;10(2):365-389. doi: 10.1016/j.jcmgh.2020.03.008. Epub 2020 Apr 11. Cell Mol Gastroenterol Hepatol. 2020. PMID: 32289499 Free PMC article.
-
Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation.Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):16999-7004. doi: 10.1073/pnas.1311657110. Epub 2013 Sep 30. Proc Natl Acad Sci U S A. 2013. PMID: 24082103 Free PMC article.
-
Inflammation drives dysbiosis and bacterial invasion in murine models of ileal Crohn's disease.PLoS One. 2012;7(7):e41594. doi: 10.1371/journal.pone.0041594. Epub 2012 Jul 25. PLoS One. 2012. PMID: 22848538 Free PMC article.
-
Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.Immunol Rev. 2014 Jul;260(1):249-60. doi: 10.1111/imr.12193. Immunol Rev. 2014. PMID: 24942694 Review.
-
The effect of NOD2 on the microbiota in Crohn's disease.Curr Opin Biotechnol. 2016 Aug;40:97-102. doi: 10.1016/j.copbio.2016.02.028. Epub 2016 Mar 29. Curr Opin Biotechnol. 2016. PMID: 27035071 Free PMC article. Review.
Cited by
-
Loss of NOD2 in macrophages improves colitis and tumorigenesis in a lysozyme-dependent manner.Front Immunol. 2023 Oct 9;14:1252979. doi: 10.3389/fimmu.2023.1252979. eCollection 2023. Front Immunol. 2023. PMID: 37876927 Free PMC article.
-
NOD-like receptors mediate homeostatic intestinal epithelial barrier function: promising therapeutic targets for inflammatory bowel disease.Therap Adv Gastroenterol. 2023 Sep 9;16:17562848231176889. doi: 10.1177/17562848231176889. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 37701792 Free PMC article. Review.
-
Genotype-protein phenotype characterization of NOD2 and IL23R missense variants associated with inflammatory bowel disease: A paradigm from molecular modelling, dynamics, and docking simulations.Front Med (Lausanne). 2023 Jan 10;9:1090120. doi: 10.3389/fmed.2022.1090120. eCollection 2022. Front Med (Lausanne). 2023. PMID: 36703890 Free PMC article.
-
NOD-like receptors in autoimmune diseases.Acta Pharmacol Sin. 2021 Nov;42(11):1742-1756. doi: 10.1038/s41401-020-00603-2. Epub 2021 Feb 15. Acta Pharmacol Sin. 2021. PMID: 33589796 Free PMC article. Review.
-
NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.J Clin Invest. 2021 Mar 1;131(5):e140624. doi: 10.1172/JCI140624. J Clin Invest. 2021. PMID: 33444291 Free PMC article.
References
-
- Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27:549–559. - PubMed
-
- Chen G, Shaw MH, Kim YG, Nunez G. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 2009;4:365–398. - PubMed
-
- Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 2014;14:9–23. - PubMed
-
- Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J. Biol. Chem. 2007;282:36223–36229. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
